EU advises adding condition to AstraZeneca label

In a statement on Friday, the EU drug regulator said it reviewed cases of six people who had capillary leak syndrome after they had received a shot of the AstraZeneca vaccine.

from News-Economic Times https://ift.tt/3pXczhn

Related Posts:

0 Comments:

Post a Comment